SERENTIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Serentil, and when can generic versions of Serentil launch?
Serentil is a drug marketed by Novartis and is included in three NDAs.
The generic ingredient in SERENTIL is mesoridazine besylate. There are two drug master file entries for this compound. Additional details are available on the mesoridazine besylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SERENTIL?
- What are the global sales for SERENTIL?
- What is Average Wholesale Price for SERENTIL?
Summary for SERENTIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Patent Applications: | 3,893 |
| DailyMed Link: | SERENTIL at DailyMed |
US Patents and Regulatory Information for SERENTIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | SERENTIL | mesoridazine besylate | CONCENTRATE;ORAL | 016997-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | SERENTIL | mesoridazine besylate | TABLET;ORAL | 016774-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | SERENTIL | mesoridazine besylate | INJECTABLE;INJECTION | 016775-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | SERENTIL | mesoridazine besylate | TABLET;ORAL | 016774-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | SERENTIL | mesoridazine besylate | TABLET;ORAL | 016774-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | SERENTIL | mesoridazine besylate | TABLET;ORAL | 016774-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
